Skip to content
Thomas Ciulla MD PC
  • Blog Homepage
  • Return to Main Site
April 11, 2020

Diabetic macular edema, a leading cause of vision loss, is treated less intensely and shows worse outcomes than in clinical trials.

Just published…

Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular edema: a real-world analysis of 28 658 patient eyes


Luxturna serves as a model for other gene therapy candidates
Just published….Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for…

Copyright © 2017 | Terms of Use | Privacy Policy
NOTICE: Individual surgical results may vary. Patients should discuss with their physician whether surgery is right for them and the risks involved. Click here for more information.
  • Kale by LyraThemes.com.